Housby, John N and Mann, Nicholas H.. (2009) Phage therapy. Drug Discovery Today, Vol.14 (No.11-12). pp. 536-540. ISSN 1878-5832

Full text not available from this repository.

Abstract

There is a renaissance of interest in the antimicrobial potential of phages as more pathogens become multiply antibiotic resistant. Phage therapy is not a new concept, and it is important to ask why it is not part of the current repertoire of western medicine despite the fact that it has been continuously and extensively used in Eastern Europe for almost a century. Answering this question successfully will, largely, determine whether phage therapy can gain the credibility needed to overcome the scientific, financial and regulatory hurdles facing its adoption in mainstream clinical practice. Despite a paucity of such information from human studies, pharmacokinetic data and clinical outcomes from animal studies are currently providing convincing evidence for the safety and efficacy of phage therapy.

Item Type:	Journal Article
Subjects:	Q Science > Q Science (General)
Divisions:	Faculty of Science > Life Sciences (2010- )
Journal or Publication Title:	Drug Discovery Today
Publisher:	Elsevier Ltd.
ISSN:	1878-5832
Official Date:	2009
Volume:	Vol.14
Number:	No.11-12
Number of Pages:	5
Page Range:	pp. 536-540
Identification Number:	10.1016/j.drudis.2009.03.006
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
URI:	http://wrap.warwick.ac.uk/id/eprint/43085

Request changes or add full text files to a record

Actions (login required)

View Item